MedPath

A Usability Study of a Smoking Cessation Decision Aid in People With a Recent First Episode of Psychosis

Not Applicable
Completed
Conditions
Smoking
Psychosis
Registration Number
NCT01399112
Lead Sponsor
Northwell Health
Brief Summary

The investigators propose to recruit patients who have experienced a recent first episode of psychosis who have a chart diagnosis of Schizophrenia, Schizophrenifom, Schizoaffective Disorder, Psychosis NOS, or Bipolar I Disorder with psychotic features and self identify themselves as a current cigarette smoker. Aiding this population with smoking cessation is crucial as the majority of people with schizophrenia spectrum disorders (50-90%) smoke, which is leading to early mortality. While these individuals can benefit from standard evidence-based treatment, these treatments are underutilized. Web based programs, such as the EDSS and thetruth.com, can provide education and motivational tools to help people with a recent onset of psychosis use evidence-based smoking cessation treatments. This study aims to test these two web-based programs among young people with a recent episode of psychosis for usability and likeability and to explore whether use of these two programs will motivate users to seek smoking cessation treatment or to engage in other quitting behaviors in the month following use of the programs. Information gathered from this proposal will be used to help the researchers decide whether either of these two programs will be reasonable to include in a larger study of a comprehensive treatment for individuals with first episode psychosis.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
11
Inclusion Criteria
  • Patients with clinical diagnoses of Schizophrenia, Schizophrenifom, Schizoaffective Disorder, Psychosis NOS, or Bipolar I Disorder with psychotic features
  • Diagnosed with one of above diagnoses within the past five years
  • Ages 15-30 years old.
  • Self-identified current cigarette smokers
  • 5th grade reading level
  • Willing to be audio recorded.
  • Willing and legally able to provide informed consent to participate in the study or have a guardian provide informed consent with assent of a minor
Exclusion Criteria
  • Physically unable to use a computer with assistance.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
number of cigarettes smokedOne month

Self-report of number of cigarettes smoked at baseline and at one month follow-up

Secondary Outcome Measures
NameTimeMethod
SatisfactionImmediately (up to 10 minutes) following the use of one of the web-based programs.

Immediately after using the assigned web-based program, the participant will be asked a series of questions regarding what they liked, did not like, found easy to use or found difficult to use when engaging with the computer program. These questions take approximately 5-10 minutes to answer.

Trial Locations

Locations (1)

Zucker Hillside Hospital

🇺🇸

Glen Oaks, New York, United States

Zucker Hillside Hospital
🇺🇸Glen Oaks, New York, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.